Home › Funds › RITHOLTZ WEALTH MANAGEMENT › GILD

RITHOLTZ WEALTH MANAGEMENT position in GILD

GILEAD SCIENCES INC · Health Care

RITHOLTZ WEALTH MANAGEMENT reported holding 135,292 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$17.1M, representing 0.27% of its reported portfolio and ranking #45 among its reported holdings. RITHOLTZ WEALTH MANAGEMENT has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)135.29K sh
Reported value held$17.09M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RITHOLTZ WEALTH MANAGEMENT's GILD position evolved

RITHOLTZ WEALTH MANAGEMENT first disclosed a stake in GILD in Q3 2023 at 62,382 shares (US$4.7M). The position peaked in Q1 2026 at 139,243 shares, worth US$19.4M. Across 12 filings, RITHOLTZ WEALTH MANAGEMENT increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 135,292 shares valued at US$17.1M — a reduction of -3,951 shares quarter over quarter.. Notable position changes include a 25% trim in Q2 2024 (shares rose 22% over the following quarter), a 81% increase in Q4 2024 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 62.38K $4.67M New
Q4 2023 64.04K $5.19M Add
Q1 2024 59.95K $4.39M Reduce
Q2 2024 44.72K $3.07M Reduce
Q3 2024 48.84K $4.09M Add
Q4 2024 88.23K $8.15M Add
Q1 2025 102.44K $11.48M Add
Q2 2025 115.17K $12.77M Add
Q3 2025 127.45K $14.15M Add
Q4 2025 135.32K $16.61M Add
Q1 2026 139.24K $19.41M Add
Q2 2026 135.29K $17.09M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has RITHOLTZ WEALTH MANAGEMENT held GILD?

RITHOLTZ WEALTH MANAGEMENT has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is RITHOLTZ WEALTH MANAGEMENT's current position in GILD?

As of Q2 2026, RITHOLTZ WEALTH MANAGEMENT holds 135.29K shares of GILD (GILEAD SCIENCES INC), valued at $17.09M, representing 0.27% of its reported portfolio and ranking #45.

Has RITHOLTZ WEALTH MANAGEMENT been buying or selling GILD?

In the latest 13F filing (Q2 2026), RITHOLTZ WEALTH MANAGEMENT reduced its position in GILD. The position peaked in Q1 2026 at 139.24K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.